Longs Drug Stores Confirms Receipt of Expression of Interest from Walgreens
14 Setembro 2008 - 4:01PM
PR Newswire (US)
WALNUT CREEK, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Longs Drug
Stores Corporation ("Longs") (NYSE:LDG) today confirmed that it had
received an unsolicited, non-binding expression of interest from
Walgreens. The expression of interest suggests an offer of $75.00
per share in cash for all of Longs' outstanding shares and is
subject to diligence and negotiating a definitive agreement. Longs'
Board of Directors will consider the expression of interest, with
the assistance of its financial and legal advisors, in accordance
with the terms of its existing merger agreement with CVS Caremark
Corporation. Longs urges its stockholders to defer making any
determination with respect to the proposal from Walgreens. Longs
cautioned that no assurances can be given that the expression of
interest from Walgreens will result in a transaction with Longs, at
the price set forth in the expression of interest or otherwise.
Longs' Board of Directors continues to recommend to its
stockholders that they accept the tender offer by CVS Caremark and
tender their shares of Longs in that tender offer. About Longs Drug
Stores Headquartered in Walnut Creek, California, Longs Drug Stores
is one of the most recognized retail drug store chains on the West
Coast and in Hawaii. The Company operates 521 retail pharmacies and
offers a wide assortment of merchandise focusing on health,
wellness, beauty and convenience. Longs also provides pharmacy
benefit management services and Medicare beneficiary prescription
drug plans through its wholly-owned subsidiary, RxAmerica, LLC.
Additional information about Longs and its services is available at
http://www.longs.com/ and more information about RxAmerica is
available at http://www.rxamerica.com/. Forward-looking statements
This announcement contains certain forward-looking statements.
These forward-looking statements may be identified by words such as
'believes', 'expects', 'anticipates', 'projects', 'intends',
'should', 'seeks', 'estimates', 'future' or similar expressions or
by discussion of, among other things, strategy, goals, plans or
intentions. Various factors may cause actual results to differ
materially in the future from those reflected in forward- looking
statements contained in this announcement, among others, the risks
that the expression of interest from Walgreens will not result in a
transaction with Longs, at the price set forth in the expression of
interest or otherwise, regulatory and litigation matters and risks;
risks that conditions to closing of the Company's transaction with
CVS may not be satisfied and other risks to consummation of the
Company's transaction with CVS, including the risk that the
transaction will not be consummated within the expected time
period. Additional Information and Where to Find It This
announcement is for informational purposes only and does not
constitute an offer to purchase or a solicitation of an offer to
sell Longs' common stock. The tender offer is being made pursuant
to a tender offer statement on Schedule TO (including the offer to
purchase, letter of transmittal and other related tender offer
materials) filed by CVS Caremark with the Securities and Exchange
Commission (SEC) on August 18, 2008. Longs filed a
solicitation/recommendation statement with respect to the tender
offer on Schedule 14D-9 on August 18, 2008. These materials, as
they may be amended from time to time, contain important
information, including the terms and conditions of the offer and
Longs' Board of Directors recommendation of the tender offer, that
should be read carefully before any decision is made with respect
to the tender offer. The solicitation/recommendation statement and
related materials may also be obtained for free by contacting (925)
979-3979. For Longs Drug Stores: Joele Frank / Steve Frankel /
Jamie Moser Joele Frank, Wilkinson Brimmer Katcher (212) 355-4449
DATASOURCE: Longs Drug Stores Corporation CONTACT: Joele Frank, or
Steve Frankel, or Jamie Moser, all of Joele Frank, Wilkinson
Brimmer Katcher, +1-212-355-4449, for Longs Drug Stores Corporation
Web site: http://www.longs.com/
Copyright
Longs Drug Stores (NYSE:LDG)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Longs Drug Stores (NYSE:LDG)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Longs Drug Stores Corp da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Longs Drug Stores Corp.